VIT
vitrin
Gene Context Sentence
Table 2. Analysis of context sentence of VIT gene in 6 abstracts.
PMID | Gene Context Sentence |
---|---|
32322486 | Intravenous (IV) Vitamin C (Vit-C) has emerged as one of the other alternatives for this purpose. […] Here we review the effects of IV Vit-C on the immune system response, the antiviral properties of IV Vit-C, and finally the antioxidant properties of IV Vit-C to specifically address the cytokines’ storm characteristic of the Acute Respiratory Distress Syndrome (ARDS) that occur in the later cycle of the Covid19 infectious disease. |
32582329 | There is no evidence found that supplement can cure the immune system except Vit C, which is one of the best way to improve immune system. |
32904593 | Here, we hypothesize that a single large dose of vitamin D (Vit D) could be an option for trial in COVID-19. […] Vit D deficiency or insufficiency is very common in the general population as well as in patients with COVID-19. […] It has been shown that low Vit D level is associated with viral infection, and Vit D supplementation is beneficial for people infected with viruses, such as HIV and hepatitis C virus. […] Clinical studies have shown that Vit D can exert anticoagulant effects. […] Vit D, a lipid-soluble vitamin, can be administered as a draught. […] Vit D supplementation is safe and has rare toxic events. […] In addition, the cost of Vit D is fairly low. […] Based on these observations, we speculate that a single dose of 300,000 IU Vit D may have a role in the prevention and treatment of COVID-19. |
33138949 | The manuscript “Covid-19 And Vit-D: Disease Mortality Negatively Correlates with Sunlight Exposure” held our attention as we found fatal shortcomings that invalidates the analyses and conclusions. |
33224428 | We evaluated the frequency and severity of COVID-19 infection in a cohort of 211 subjects referring to our center for the regular administration of venom immunotherapy (VIT). […] We reported only an isolated positivity of COVID-19 in the overall group; whereas none suffered from upper airway symptoms associated with COVID-19 (fever, cough, dyspnoea, sore throat, anosmia, and/or ageusia). […] Even though the demographic characteristics pose a substantial risk for such a population, we suggest that a regular administration of VIT may help in the development of an immunological milieu able to down modulate the Th1/Th17 environment that has been linked to inflammatory manifestations of COVID-19. […] To the best of our knowledge, this is the first description of the incidence of COVID-19 infection in Hymenoptera venom allergic patients treated with VIT, suggesting indirectly that venom immune tolerance-inducing treatment may be capable of reducing the aberrant inflammatory response induced by the virus in this specific population. |
33249121 | According to expert consensus, the time interval between Hymenoptera venom immunotherapy (VIT) injections can be extended up to 12 weeks, without significant impact on efficacy and safety. […] To provide advice on how to resume VIT safely after a long delay from the last injection considering the potential risk factors for side effects, without starting again with the induction phase. […] All the patients who delayed VIT because of the pandemic were consecutively enrolled in this single-center study. […] The time extension was decided according to their risk profile (eg, long prepandemic time interval, severe pre-VIT reaction, older age, multitreatments), and correlation analyses were performed to find potential risk factors of side effects. […] The mean delay from the pre- (7 weeks) to the postpandemic VIT interval (15.5 weeks) was 8.5 weeks. […] The total amount of the prepandemic VIT maintenance dose was safely administered in 1 day in 78% of patients, whereas only 3, of 87, experienced side effects, and their potential risk factors were identified in bee venom allergy and recent VIT initiation. […] In a real-world setting, long VIT delays may be safe and well tolerated, but more caution should be paid in resuming VIT in patients with long prepandemic maintenance interval, severe pre-VIT reaction, recent VIT initiation, older age, multidrug treatments, and bee venom allergy. […] This is useful in any case of long, unplanned, and unavoidable VIT delay. |